A study to assess the safety and efficacy of full dose of Sofosbuvir and Daclatasvir in ESRD patients on Haemodialysis at GMC Anantnag. VER [Internet]. 2025 Nov. 1 [cited 2026 Aug. 28];8(5s):121-7. Available from: https://verjournal.com/index.php/ver/article/view/442